Cerecin   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Singapore Singapore (2001)

Organization Overview

First Clinical Trial
2004
NCT00142805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Accera, Inc. | Cerecin